Mucosal Bicarbonate Barrier
Mucosal Bicarbonate Barrier - Related Videos
01:25
Mucosal Barrier of the Stomach
0 Views •
2024
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl. Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
08:25
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
0 Views •
Cited by 5 •
2014
A mouse model of human endoscopic skull base reconstruction has been developed that creates a semipermeable interface between the brain and nose using nasal mucosal grafts. This method allows researchers to study delivery to the central nervous system of high molecular weight therapeutics which are otherwise excluded by the blood-brain barrier when administered systemically.
01:29
Roles of Electrolytes: Chloride and Bicarbonate
0 Views •
2024
Chloride ions contribute to the osmotic pressure gradient distinguishing the intracellular fluid (ICF) from the extracellular fluid (ECF). They counterbalance positively charged ions in the ECF and ensure its electrochemical stability. The renal system's process of chloride absorption and release generally mirrors that of sodium ions. Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting, or...
01:22
Bicarbonate-Carbonic Acid Buffer
0 Views •
2024
The carbonic acid-bicarbonate buffer system is critical for maintaining the body's pH balance. It operates on the equilibrium: H2CO3 ⇋ H+ + HCO3- In this system, bicarbonate ions (HCO3⁻) act as weak bases, and carbonic acid (H₂CO₃) serves as a weak acid. This dynamic equilibrium enables the system to respond effectively to changes in pH. When hydrogen ion (H+) levels increase, causing a drop in pH, the equilibrium shifts to the left, converting hydrogen ions into carbonic acid. The enzyme...
02:55
Quantification of Immune Mediator Levels in Human Mucosal Lining Fluid
0 Views •
2025
This video demonstrates the quantification of immune mediator levels in neonatal human nasal mucosal lining fluid extract. An electrochemiluminescence-based multiplex assay system measures these mediators by evaluating the intensity of emitted light when they are excited.
FAQs
Epithelial cells release bicarbonate into the mucus layer covering the surface. Within this layer, bicarbonate neutralizes hydrogen ions from the lumen, creating a near-neutral environment immediately adjacent to the cells. This localized pH control limits acid exposure even when the stomach or intestine contains substantially more acidic contents.
Mucus provides the overlying compartment in which secreted bicarbonate can act. By retaining bicarbonate near the epithelium, the layer supports neutralization at the cell surface rather than allowing acid to contact epithelial cells directly. The protective effect therefore depends on both epithelial secretion and the spatial organization of mucus above the tissue.
The barrier helps limit injury caused by acid and other chemical challenges at epithelial surfaces. Its importance is greatest where epithelial tissue faces potentially damaging luminal contents, particularly in the stomach and intestine. Maintaining protection at the cell surface supports epithelial integrity despite exposure to chemically aggressive conditions within the lumen.
Regulation determines how effectively epithelial surfaces can sustain bicarbonate-mediated protection. Pharmacological research therefore examines mechanisms that preserve epithelial defense, enhance bicarbonate secretion, or reduce conditions that promote gastrointestinal injury. This regulatory perspective connects normal mucosal physiology with the evaluation of treatments for acid-related damage and medication-associated harm.
Drug evaluation can include whether a treatment preserves epithelial protection or strengthens bicarbonate secretion. This is particularly relevant for therapies intended to reduce gastrointestinal damage, as well as for assessing unwanted injury associated with medications such as nonsteroidal anti-inflammatory drugs. The barrier provides a physiological framework for interpreting protective or damaging effects at the mucosal surface.
Nonsteroidal anti-inflammatory drugs are relevant because the mucosal bicarbonate barrier provides a framework for understanding medication-associated gastrointestinal damage. In pharmacology, examining this relationship helps researchers consider whether drug exposure compromises mucosal defense and how protective strategies might preserve epithelial surfaces. The same framework also supports comparison of approaches that enhance bicarbonate secretion or otherwise limit injury.
Studies can assess whether an intervention preserves epithelial protection, enhances bicarbonate secretion, or reduces gastrointestinal damage. These outcomes connect a treatment's effects with the underlying mucosal defense system rather than focusing only on luminal acidity. Such evaluations are useful for developing therapies aimed at acid-related disease and for understanding how medications influence gastrointestinal safety.